Drawing for MR. GENE - BEST PRICE DNA

USPTO serial 77329472

MR. GENE - BEST PRICE DNA

Reviewed by CopyMark Law Group

Reg. 3681939Status 710
Filing date
Status date
Registration date
Sep 15, 2009
Examiner
FROMM, MARTHA L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MR. GENE - BEST PRICE DNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Phil Makrogiannis

Phil Makrogiannis Life Technologies Corporation5791 Van Allen WayCarlsbad, CA 92008UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001chemical preparations for laboratory analysis in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; chemical preparations for scientific purposes in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; bacteria preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biological materials for scientific and research laboratories, namely, proteins, genes, especially genes comprising 80 to 150 base pairs, DNA, especially deoxyribonucleic acid comprising 80 to 150 base pairs, RNA and modifications thereof; diagnostic materials for scientific and research purposes, namely, proteins, genes, especially genes comprising 80 to 150 base pairs, DNA, especially deoxyribonucleic acid comprising 80 to 150 base pairs, RNA and modifications thereof; enzymes and enzyme preparations for use in the field of food manufacture, waste treatment, fermentation, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; genetic materials for scientific and research purposes, namely, deoxyribonucleic acid, especially deoxyribonucleic acid comprising 80 to 150 base pairs and genes, especially genes comprising 80 to 150 base pairsSECTION 8 - CANCELLED—
005medicines for human-medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, Alzheimer's and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; bacteriological preparations for medical and veterinary purposes for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; germicides for medical and laboratory equipment, institutional, domestic uses; vermicides for medical and laboratory equipment, institutional, domestic, residential uses; fungicides for medical and laboratory equipment, institutional, domestic uses; biological materials for medical diagnostic laboratories, namely, proteins, genes, especially genes comprising 80 to 150 base pairs, DNA, especially deoxyribonucleic acid comprising 80 to 150 base pairs, RNA and modifications thereof; diagnostic materials for clinical and medical laboratory purposes, namely, proteins, genes, especially genes comprising 80 to 150 base pairs, DNA, especially deoxyribonucleic acid comprising 80 to 150 base pairs, RNA and modifications thereof; pharmaceutical preparations for clinical and medical laboratory purposes, namely, deoxyribonucleic acid, especially deoxyribonucleic acid comprising 80 to 150 base pairs and genes, especially genes comprising 80 to 150 base pairsSECTION 8 - CANCELLED—
007Filling machines; membranes for use with electric pumps; mixing machines; electric pumps; regulators being parts of machines; industrial robot machines; centrifugal separator machinesSECTION 8 - CANCELLED—
009Scientific and laboratory equipment, namely, automatic machines for the synthesis of deoxyribonucleic acids; robot machines for laboratory purposes; computer terminals; computer programs for use in database management in the fields of biotechnology and molecular biology; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations, diagnostic preparations; computer operating programs; computer peripheral devices; computer keyboards; blank magnetic data carriers; blank optical disks; data processors; computer memories; blank floppy disks; blank hard drives for computers; printers for use with computers; computer interface boards; laptop computers; data processors, namely, readers and scanners; computer mouse; semiconductors; computer modems; computer monitors; computer hardware; and notebook computers; pressure regulators for use in controlling the flow of cryogenic liquidsSECTION 8 - CANCELLED—
042Computer services, namely, updating of computer software for others, consulting in the field of biotechnology, designing computer software for others, maintenance of computer software for others, leasing of computer software, computer programming for others, leasing of computers, and recovery of computer data; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; laboratory services for others in the fields of bacteriology and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics research, engineering and machine engineering; consultancy pertaining to pharmacology; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental assessment, compliance and planning; technical project planning and consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy research, engineering, and machine engineering; technical project planning and consulting services regarding laboratory research in the field of cosmetics; and quality control for othersSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 22, 2016C8..CANCELLED SEC. 8 (6-YR)—
Jul 23, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 21, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 2, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 1, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 15, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 30, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2009NPUBNOTICE OF PUBLICATION—
May 26, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 18, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 18, 2009XAECEXAMINER'S AMENDMENT ENTERED—
May 18, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 18, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
May 18, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
May 6, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 17, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 8, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 7, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Mar 20, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 20, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 20, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 27, 2008GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 27, 2008GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 27, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 8, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 8, 2008ALIEASSIGNED TO LIE—
Aug 28, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2008DOCKASSIGNED TO EXAMINER—
Nov 19, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance